Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in the Treatment of Pathological Gambling
NCT00245583Phase 3Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Oct 2005
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of topiramate in gambling disorder (GD), sponsored by Icahn School of Medicine at Mount Sinai. Started Oct 2005; status: terminated.
02
Drugs
topiramate
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on NCT00245583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245583.